As of January 1st 2014, Michel Bracké, will assume the role of CEO for Nicoccino. Nicoccino is a spin off company from FFT Medical AB.
Since July 2013, Michel Bracké has assumed the role of CEO under a consultancy contract. During this period the strategy, product name and positioning were defined helping the company in a new capitalization round.
The focus now will be to launch Nicoccino, a powerful pure nicotine product for smokers and vapers, in the United Kingdom during 2014. Nicoccino is also planning a listing on Nasdaq OMX First North later this spring.